Annual CAPEX
$6.89 M
+$3.68 M+114.52%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual capital expenditures is $6.89 million, with the most recent change of +$3.68 million (+114.52%) on December 31, 2023.
- During the last 3 years, RVNC annual CAPEX has risen by +$2.67 million (+63.33%).
- RVNC annual CAPEX is now -97.81% below its all-time high of $315.01 million, reached on December 31, 2018.
Performance
RVNC CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$61.00 K
+$3.05 M+102.04%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly capital expenditures is $61.00 thousand, with the most recent change of +$3.05 million (+102.04%) on September 30, 2024.
- Over the past year, RVNC quarterly CAPEX has dropped by -$4.44 million (-98.65%).
- RVNC quarterly CAPEX is now -99.98% below its all-time high of $309.54 million, reached on December 31, 2018.
Performance
RVNC Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$4.02 M
-$4.44 M-52.48%
September 30, 2024
Summary
- As of February 7, 2025, RVNC TTM capital expenditures is $4.02 million, with the most recent change of -$4.44 million (-52.48%) on September 30, 2024.
- Over the past year, RVNC TTM CAPEX has dropped by -$2.37 million (-37.11%).
- RVNC TTM CAPEX is now -98.72% below its all-time high of $315.03 million, reached on March 31, 2019.
Performance
RVNC TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
RVNC CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +114.5% | -98.7% | -37.1% |
| 3 y3 years | +63.3% | +102.4% | -51.1% |
| 5 y5 years | -97.8% | -95.9% | +24.5% |
RVNC CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -33.6% | +114.5% | -98.8% | +102.0% | -64.1% | +53.3% |
| 5 y | 5-year | -33.6% | +114.5% | -98.8% | +102.0% | -65.0% | +75.3% |
| alltime | all time | -97.8% | +4490.7% | -100.0% | +102.0% | -98.7% | +1137.5% |
Revance Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $61.00 K(-102.0%) | $4.02 M(-52.5%) |
| Jun 2024 | - | -$2.99 M(-157.8%) | $8.46 M(-24.4%) |
| Mar 2024 | - | $5.17 M(+190.8%) | $11.19 M(+62.5%) |
| Dec 2023 | $6.89 M(+114.5%) | $1.78 M(-60.5%) | $6.89 M(+7.7%) |
| Sep 2023 | - | $4.50 M(-1792.9%) | $6.39 M(+121.0%) |
| Jun 2023 | - | -$266.00 K(-130.6%) | $2.89 M(+10.3%) |
| Mar 2023 | - | $870.00 K(-32.5%) | $2.62 M(-18.3%) |
| Dec 2022 | $3.21 M(-69.1%) | $1.29 M(+28.5%) | $3.21 M(-48.9%) |
| Sep 2022 | - | $1.00 M(-286.9%) | $6.28 M(+125.9%) |
| Jun 2022 | - | -$536.00 K(-136.8%) | $2.78 M(-64.3%) |
| Mar 2022 | - | $1.46 M(-66.6%) | $7.79 M(-24.9%) |
| Dec 2021 | $10.38 M(+146.1%) | $4.36 M(-274.4%) | $10.38 M(+26.1%) |
| Sep 2021 | - | -$2.50 M(-155.8%) | $8.23 M(-28.5%) |
| Jun 2021 | - | $4.48 M(+11.0%) | $11.50 M(+51.4%) |
| Mar 2021 | - | $4.04 M(+82.8%) | $7.59 M(+80.1%) |
| Dec 2020 | $4.22 M(+30.5%) | $2.21 M(+184.2%) | $4.22 M(+83.7%) |
| Sep 2020 | - | $777.00 K(+35.4%) | $2.29 M(-23.6%) |
| Jun 2020 | - | $574.00 K(-12.6%) | $3.00 M(+7.1%) |
| Mar 2020 | - | $657.00 K(+128.9%) | $2.80 M(-13.2%) |
| Dec 2019 | $3.23 M(-99.0%) | $287.00 K(-80.7%) | $3.23 M(-99.0%) |
| Sep 2019 | - | $1.48 M(+295.7%) | $312.49 M(-0.5%) |
| Jun 2019 | - | $375.00 K(-65.4%) | $314.04 M(-0.3%) |
| Mar 2019 | - | $1.08 M(-99.6%) | $315.03 M(+0.0%) |
| Dec 2018 | $315.01 M | $309.54 M(>+9900.0%) | $315.01 M(+5189.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $3.03 M(+121.8%) | $5.96 M(+72.5%) |
| Jun 2018 | - | $1.37 M(+28.0%) | $3.45 M(+1.6%) |
| Mar 2018 | - | $1.07 M(+118.9%) | $3.40 M(+29.4%) |
| Dec 2017 | $2.63 M(-24.4%) | $488.00 K(-7.9%) | $2.63 M(-1.1%) |
| Sep 2017 | - | $530.00 K(-59.6%) | $2.65 M(+16.3%) |
| Jun 2017 | - | $1.31 M(+342.9%) | $2.28 M(-25.8%) |
| Mar 2017 | - | $296.00 K(-42.9%) | $3.08 M(-11.4%) |
| Dec 2016 | $3.47 M(+4.3%) | $518.00 K(+227.8%) | $3.47 M(+1.1%) |
| Sep 2016 | - | $158.00 K(-92.5%) | $3.43 M(-10.4%) |
| Jun 2016 | - | $2.10 M(+204.9%) | $3.83 M(+72.8%) |
| Mar 2016 | - | $690.00 K(+44.1%) | $2.22 M(-33.4%) |
| Dec 2015 | $3.33 M(-52.3%) | $479.00 K(-14.0%) | $3.33 M(-24.0%) |
| Sep 2015 | - | $557.00 K(+13.4%) | $4.38 M(-25.1%) |
| Jun 2015 | - | $491.00 K(-72.7%) | $5.85 M(-24.9%) |
| Mar 2015 | - | $1.80 M(+17.6%) | $7.79 M(+11.7%) |
| Dec 2014 | $6.97 M(+7.7%) | $1.53 M(-24.4%) | $6.97 M(-24.6%) |
| Sep 2014 | - | $2.03 M(-16.7%) | $9.25 M(+22.1%) |
| Jun 2014 | - | $2.43 M(+147.0%) | $7.58 M(+6.2%) |
| Mar 2014 | - | $985.00 K(-74.1%) | $7.14 M(+10.2%) |
| Dec 2013 | $6.48 M(+1930.4%) | $3.81 M(+974.9%) | $6.48 M(+142.4%) |
| Sep 2013 | - | $354.00 K(-82.2%) | $2.67 M(+15.3%) |
| Jun 2013 | - | $1.99 M(+513.2%) | $2.32 M(+613.2%) |
| Mar 2013 | - | $325.00 K | $325.00 K |
| Dec 2012 | $319.00 K(+112.7%) | - | - |
| Dec 2011 | $150.00 K | - | - |
FAQ
- What is Revance Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Revance Therapeutics?
- What is Revance Therapeutics annual CAPEX year-on-year change?
- What is Revance Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Revance Therapeutics?
- What is Revance Therapeutics quarterly CAPEX year-on-year change?
- What is Revance Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Revance Therapeutics?
- What is Revance Therapeutics TTM CAPEX year-on-year change?
What is Revance Therapeutics annual capital expenditures?
The current annual CAPEX of RVNC is $6.89 M
What is the all time high annual CAPEX for Revance Therapeutics?
Revance Therapeutics all-time high annual capital expenditures is $315.01 M
What is Revance Therapeutics annual CAPEX year-on-year change?
Over the past year, RVNC annual capital expenditures has changed by +$3.68 M (+114.52%)
What is Revance Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of RVNC is $61.00 K
What is the all time high quarterly CAPEX for Revance Therapeutics?
Revance Therapeutics all-time high quarterly capital expenditures is $309.54 M
What is Revance Therapeutics quarterly CAPEX year-on-year change?
Over the past year, RVNC quarterly capital expenditures has changed by -$4.44 M (-98.65%)
What is Revance Therapeutics TTM capital expenditures?
The current TTM CAPEX of RVNC is $4.02 M
What is the all time high TTM CAPEX for Revance Therapeutics?
Revance Therapeutics all-time high TTM capital expenditures is $315.03 M
What is Revance Therapeutics TTM CAPEX year-on-year change?
Over the past year, RVNC TTM capital expenditures has changed by -$2.37 M (-37.11%)